PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in PharmaCyte Biotech, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −2 vs. Q2 2022
- Shares held
- 4.98M
- +1.06M (+27.1%) vs. Q2 2022
- Total value
- $12.0M
- +$3.17M (+36.0%) vs. Q2 2022
- New holders
- 2
- 9 more added
- Sold out
- 4
- 10 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 31 | $0 | 0.00% | −2,495−98.8% | Reduced |
| Bank of America Corp | 54 | $0 | 0.00% | −1,680−96.9% | Reduced |
| Tower Research Capital LLC (TRC) | 97 | $0 | 0.00% | −1,064−91.6% | Reduced |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 138 | $0 | 0.00% | −1−0.7% | Reduced |
| Royal Bank of Canada | 151 | $0 | 0.00% | +53+54.1% | Added |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 7 | $17 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 27 | $65 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 234 | $562 | 0.00% | −28−10.7% | Reduced |
| Aspire Private Capital, LLC | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,758 | $5.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 11,148 | $27.0K | 0.00% | +2,267+25.5% | Added |
| Susquehanna International Group, LLP | 16,624 | $40.0K | 0.00% | −61,985−78.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 24,800 | $60.0K | 0.00% | −1,400−5.3% | Reduced |
| Millennium Management LLC | 25,018 | $60.0K | 0.00% | +7,499+42.8% | Added |
| Northern Trust Corp | 37,630 | $90.0K | 0.00% | 00.0% | Unchanged |
| Davy Global Fund Management Ltd | 38,771 | $93.0K | 0.02% | +38,771 | New |
| Price T Rowe Associates Inc | 47,000 | $113.0K | 0.00% | −15,000−24.2% | Reduced |
| State Street Corp | 62,600 | $150.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 65,420 | $157.0K | 0.01% | +10,493+19.1% | Added |
| Group One Trading, L.P. | 75,052 | $180.0K | 0.01% | +6,011+8.7% | Added |
| Geode Capital Management, LLC | 175,607 | $421.0K | 0.00% | 00.0% | Unchanged |
| Csenge Advisory Group | 200,104 | $480.0K | 0.04% | +200,104 | New |
| Equitec Proprietary Markets, LLC | 330,694 | $794.0K | 0.35% | −12,300−3.6% | Reduced |
| Sabby Management, LLC | 567,600 | $1.36M | 2.95% | −493,811−46.5% | Reduced |
| K2 Principal Fund, L.P. | 611,163 | $1.47M | 0.35% | +520,068+570.9% | Added |
| Vanguard Group Inc | 643,174 | $1.54M | 0.00% | +800+0.1% | Added |
| Shay Capital LLC | 1,015,666 | $2.44M | 1.22% | +32,968+3.4% | Added |
| Ayrton Capital LLC | 1,033,130 | $2.48M | 4.35% | +880,000+574.7% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −31,696−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −15,290−100.0% | Sold out |
| Blue Bell Private Wealth Management, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Heritage Financial Services, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |